Defence Research And Development Organisation English news | Defence Research And Development Organisation, Latest News & Live Updates in English | English News (Latest English News) at Lokmattimes.com

Defence Research and Development Organisation's (DRDO) on Tuesday issued some important guidelines issued with regard to it's anti-Covid-19 drug. The 2DG medicine can be given to Covid-19 patients under the care and prescription of doctors. Directions for usage of this drug for Covid-19 patients as per DCGI approval are given below.The 2-DG drug comes in powder form in the sachet, which is taken orally by dissolving it in water. It accumulates in the virus-infected cells and prevents virus growth by stopping viral synthesis and energy production. Its selective accumulation in virally infected cells makes this drug unique. The drug reportedly reduces a patient's average recovery time by two and a half days and oxygen demand by upto 40 per cent, the Union Health Ministry said.Important Guidelines With Regard to DRDO Anti-COVID Drug 2DG:The 2DG is approved for emergency use as an adjunct therapy to the standard of care in the treatment of COVID patients in hospital settings.Ideally, 2DG should be prescribed as early as possible by doctors for moderate to severe COVID patients for a maximum duration of up to 10 days.Uncontrolled diabetes severe cardiac problem ARDS severe hepatic and renal impairment patients have not been studied yet with 2DG, and hence caution should be exercised.2DG should not be given to pregnant and lactating women and patients below 18 years.Patients and attendants are advised to request the hospital to contact Dr Reddy’s lab Hyderabad for medicine supply at email: 2DG@drreddys.com.

Defence Research And Development OrganisationFOLLOW

Defence research and development organisation, Latest News

Srinagar, June 9 The Lieutenant Governor of Jammu and Kashmir, Manoj Sinha, on Wednesday inaugurated a 500-bed Covid ... ...

The Defence Research and Development Organisation (DRDO), which developed 2 -Deoxy-D-Glucose (2-DG), a drug used for the treatment of COVID-19 patients, has called for Expression of Interest (EoI) to transfer the technology to Indian pharmaceutical i ...

Jammu and Kashmir Lieutenant Governor Manoj Sinha on Wednesday inaugurated a 500-bedded Defence Research and Development Organisation (DRDO) COVID-19 hospital with an ICU facility, at Khonmoh in Srinagar. ...

The Defence Research and Development Organisation (DRDO), which developed 2 -Deoxy-D-Glucose (2-DG), a drug used for the treatment of COVID-19 patients, has called for Express of Interest (EOI) to transfer the technology to Indian pharmaceutical indu ...

A 500-bed Covid-19 hospital in Khonmoh area of Srinagar is in final stages of completion and will soon be open to the public. ...

New Delhi, June 1 The Defence Research and Development Organisation (DRDO) on Tuesday issued directions on how to ... ...

The Defence Research and Development Organisation's (DRDO) on Tuesday said that the anti-COVID drug 2DG is approved for emergency use as an adjunct therapy to the standard of care in the treatment of coronavirus patients in hospital settings. ...

Defence Research and Development Organisation's (DRDO) on Tuesday issued some important guidelines issued with regard to it's anti-Covid-19 drug. ... ...